Last reviewed · How we verify
Polyethylene Glycol-Based Lavage — Competitive Intelligence Brief
phase 3
Osmotic laxative / Bowel preparation agent
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Polyethylene Glycol-Based Lavage (Polyethylene Glycol-Based Lavage) — University of Calgary. Polyethylene glycol-based lavage solution mechanically cleanses and prepares the colon by osmotically drawing fluid into the bowel lumen to promote evacuation of fecal matter.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Polyethylene Glycol-Based Lavage TARGET | Polyethylene Glycol-Based Lavage | University of Calgary | phase 3 | Osmotic laxative / Bowel preparation agent | ||
| Split-dose low-volume PEG | Split-dose low-volume PEG | Kyunghee University Medical Center | marketed | Osmotic laxative / bowel preparation agent | ||
| Cool prep | Cool prep | Taejoon Pharmaceutical Co., Ltd. | phase 3 | Osmotic laxative / Bowel preparation agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Osmotic laxative / Bowel preparation agent class)
- Taejoon Pharmaceutical Co., Ltd. · 1 drug in this class
- University of Calgary · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Polyethylene Glycol-Based Lavage CI watch — RSS
- Polyethylene Glycol-Based Lavage CI watch — Atom
- Polyethylene Glycol-Based Lavage CI watch — JSON
- Polyethylene Glycol-Based Lavage alone — RSS
- Whole Osmotic laxative / Bowel preparation agent class — RSS
Cite this brief
Drug Landscape (2026). Polyethylene Glycol-Based Lavage — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycol-based-lavage. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing